Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
15241
-
15242
Source data.
Published 2025“…Under wide-field imaging in primary somatosensory and visual cortices in mice with high labeling density (80–90%), SomaFRCaMPi exhibits up to 40% higher SNR and decreased artifactual correlation across neurons. Altogether, SomaFRCaMPi improves the accuracy and scale of neuronal activity imaging at single-neuron resolution in densely labeled brain tissues due to a 2–3-fold enhanced automated neuronal segmentation, 50% higher fraction of responsive cells, up to 2-fold higher SNR compared to jRGECO1a. …”
-
15243
In vitro biophysical properties of red GECIs.
Published 2025“…Under wide-field imaging in primary somatosensory and visual cortices in mice with high labeling density (80–90%), SomaFRCaMPi exhibits up to 40% higher SNR and decreased artifactual correlation across neurons. Altogether, SomaFRCaMPi improves the accuracy and scale of neuronal activity imaging at single-neuron resolution in densely labeled brain tissues due to a 2–3-fold enhanced automated neuronal segmentation, 50% higher fraction of responsive cells, up to 2-fold higher SNR compared to jRGECO1a. …”
-
15244
Source data.
Published 2025“…Under wide-field imaging in primary somatosensory and visual cortices in mice with high labeling density (80–90%), SomaFRCaMPi exhibits up to 40% higher SNR and decreased artifactual correlation across neurons. Altogether, SomaFRCaMPi improves the accuracy and scale of neuronal activity imaging at single-neuron resolution in densely labeled brain tissues due to a 2–3-fold enhanced automated neuronal segmentation, 50% higher fraction of responsive cells, up to 2-fold higher SNR compared to jRGECO1a. …”
-
15245
Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder
Published 2023“…This study focused on the synthesis and evaluation of a novel series of benzothiazole analogues designed to target D<sub>4</sub>R. …”
-
15246
Table_3_Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy.xlsx
Published 2021“…<p>Disturbance in microbiota affects the mucosal immune response, and it is gradually recognized to be associated with the Immunoglobin A nephropathy (IgAN). This study aims to explore the potential roles of oral microbiota in disease pathogenesis. …”
-
15247
The Recovery of Plastid Function Is Required for Optimal Response to Low Temperatures in <i>Arabidopsis</i>
Published 2015“…The <i>gun5-1</i> and <i>cch</i> alleles showed an inability to recover chlorophyll biosynthesis in addition to a significant decrease in freezing tolerance. We found that the impaired plastid function in the CHLH mutant plants resulted in compromised <i>de novo</i> protein synthesis at low temperatures. …”
-
15248
Table_1_Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy.xlsx
Published 2021“…<p>Disturbance in microbiota affects the mucosal immune response, and it is gradually recognized to be associated with the Immunoglobin A nephropathy (IgAN). This study aims to explore the potential roles of oral microbiota in disease pathogenesis. …”
-
15249
Table_4_Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy.xlsx
Published 2021“…<p>Disturbance in microbiota affects the mucosal immune response, and it is gradually recognized to be associated with the Immunoglobin A nephropathy (IgAN). This study aims to explore the potential roles of oral microbiota in disease pathogenesis. …”
-
15250
Table_5_Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy.xlsx
Published 2021“…<p>Disturbance in microbiota affects the mucosal immune response, and it is gradually recognized to be associated with the Immunoglobin A nephropathy (IgAN). This study aims to explore the potential roles of oral microbiota in disease pathogenesis. …”
-
15251
Table_2_Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy.xlsx
Published 2021“…<p>Disturbance in microbiota affects the mucosal immune response, and it is gradually recognized to be associated with the Immunoglobin A nephropathy (IgAN). This study aims to explore the potential roles of oral microbiota in disease pathogenesis. …”
-
15252
-
15253
Buffers render spiking more irregular by decreasing spatial coupling.
Published 2010“…BAPTA and EGTA lead to a similar − dependence for the smaller current (squares), whereas the increased current decreases the slope to 0.6. …”
-
15254
Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
15255
Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
15256
Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
15257
Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
15258
Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
15259
Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
15260
Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”